Advertisement
Organisation › Details
Pulmocide Ltd.
Pulmocide Ltd (www.pulmocide.com) is a late-stage biopharmaceutical company developing novel therapies for patients suffering from serious acute and chronic respiratory diseases. Pulmocide’s lead product is PC945, a novel antifungal specifically designed for inhaled use to maximise the amount of drug in the lung and spare systemic exposure. This is expected to provide for superior efficacy against respiratory aspergillosis while minimizing systemic toxicities. PC945 is expected to be useful in a variety of conditions where Aspergillus has been implicated. *
Start | 2013-11-21 established (approx) | |
Industry | respiratory drug delivery technology | |
Industry 2 | anti-infective drug | |
Person | Rapeport, William Garth (Pulmocide Ltd 201311– CEO before RespiVert CEO + co-founder) | |
Person 2 | Strong, Pete (Pulmocide Ltd 201311– CSO before co-founder of Respivert) | |
Region | London, Greater London | |
Country | United Kingdom (GB) | |
Street | 44 Southampton Buildings | |
City | WC2A 1AP London | |
Tel | +44-203-763-9484 | |
Address record changed: 2021-05-29 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Pulmocide Ltd.. (5/27/21). "Press Release: Pulmocide Raises $92 Million in a Series C Financing to Fund Registration Program for PC945". London. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for Pulmocide Ltd.
- [1] Pulmocide Ltd.. (5/27/21). "Press Release: Pulmocide Raises $92 Million in a Series C Financing to Fund Registration Program for PC945". London....
- [2] Jeito Capital. (5/27/21). "Press Release: Jeito Capital Leads Oversubscribed $92 million Series C Financing Round in Pulmocide". Paris....
- [3] Pulmocide Ltd.. (3/20/17). "Press Release: Pulmocide Raises $30 Million in Series B Financing. Funding to Progress Novel Wholly-owned Compounds for RSV and Pulmonary Aspergillosis". London....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top